Beijing CapitalBio Technology Co., Ltd.

According to the WHO, 360 million individuals, or more than 5% of the world’s population, suffers disabling hearing loss. Hearing loss produces significant negative impacts on individuals’ lives as well as on society.

Aminoglycoside-Induced Deafness Gene Mutations Detection Kit is designed for a rapid and accurate detection of gene mutations related to deafness caused by the use of aminoglycosides. It employs fluorescence quantitative PCR technology and covers two mutations in one gene. It helps to identify individuals likely to suffer hearing loss after using aminoglycosides and allows precautions to be taken to avoid deafness caused by inappropriate use of aminoglycosides.

Information of the 2 Mutations

Ordering Information